1.Flipo M, Desroses M, Lecat-Guillet N, Villemagne B, Blondiaux N, Leroux F, Piveteau C, Mathys V, Flament MP, Siepmann J, Villeret V, Wohlkönig A, Wintjens R, Soror SH, Christophe T, Jeon HK, Locht C, Brodin P, Déprez B, Baulard AR, Willand N.. (2012) Ethionamide boosters. 2. Combining bioisosteric replacement and structure-based drug design to solve pharmacokinetic issues in a series of potent 1,2,4-oxadiazole EthR inhibitors., 55 (1):[PMID:22098589][10.1021/jm200825u]
2.De SS, Khambete MP, Degani MS.. (2019) Oxadiazole scaffolds in anti-tuberculosis drug discovery., 29 (16):[PMID:31296357][10.1016/j.bmcl.2019.06.054]
3.Johannes Zuegg, Alysha Elliott, Maite Amado, Emma Cowie, Ali Hinton, Geraldine Kaeslin, Angela Kavanagh, Anne Kunert, Gabriell Lowe, Soumya Ramu, Janet Reid, Robin Trauer, Mathilde Desselle, Ruth Neale, Karl Hansford, Mark Blascovich, Matthew Cooper.CO-ADD screening of MMV (CH) - Pandemic Response Box, [10.6019/CHEMBL4513161]